BRANDI KINCAID: Open Payments
NPI 1144527490 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,712 in 136 payments from 34 companies in 2025. Trend: 2023 $814 · 2024 $1,163 · 2025 $2,712
Food & beverage: $2,634Education: $78
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $747 |
| Novartis Pharmaceuticals Corporation | 16 | $336 |
| Celgene Corporation | 10 | $164 |
| GlaxoSmithKline, LLC. | 8 | $150 |
| E.R. Squibb & Sons, L.L.C. | 5 | $102 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| ARRAY BIOPHARMA INC | 6 | $96 |
| PFIZER INC. | 6 | $92 |
| Genentech USA, Inc. | 4 | $80 |
| Eisai Inc. | 3 | $77 |
Products named: VENCLEXTA, IMBRUVICA, REBLOZYL, LUTATHERA, SCEMBLIX, OJJAARA, KEYTRUDA, Lenvima.
Industry payments across MO — which companies pay providers there.
